AngioDynamics Inc (STU:UG2)
€ 5.9 0.05 (0.85%) Market Cap: 229.90 Mil Enterprise Value: 181.36 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 57/100

AngioDynamics Inc at UBS Global Healthcare Conference Transcript

May 23, 2022 / 08:15PM GMT
Release Date Price: €17.7 (-1.67%)
Seth Damergy

Hi. Well, look, thank you, everyone, for joining us today. I think, at least for me, this is the last session of the day. And I couldn't be happier to be sitting here next to these 2 gentlemen.

So I'm Seth Damergy, I lead the medical device investment banking practice at UBS. And I'm pleased to be able to introduce our next presenters or more of our fireside chat, AngioDynamics. So we have Jim Clemmer, CEO; Steve Trowbridge, CFO of the company. Two folks I've known for a very long period of time.

AngioDynamics is a NASDAQ-listed med tech company. We'll go through some Q&A. I've got an iPad up here that's going to have lots of your questions. But in the meantime, I'll get the Q&A started. So feel free to just jump in with anything that you feel is pertinent.

Questions & Answers

Seth Damergy

So gentlemen, I thought it would make sense, with everything that we're seeing in the market and even what we've heard from you about some of the macro dynamics. To start off with inflation. So from an inflation perspective, how do you see

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot